Intercellular Adhesion Molecule-1 as Target for CAR-T-Cell Therapy of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) comprises lethal malignancies with limited treatment options. Chimeric antigen receptor T (CAR-T) cell therapy is an effective immunotherapeutic strategy that has demonstrated unprecedented efficacy in the treatment of hematological malignancies but has shown lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Heng, Wang, Zeng, Kuang, Yi, Wu, Zhiguo, Zhao, Shasha, Zhang, Zongliang, Li, Hexian, Zheng, Meijun, Zhang, Nan, Long, Cheng, Guo, Wenhao, Nie, Chunlai, Yang, Hui, Tong, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539633/
https://www.ncbi.nlm.nih.gov/pubmed/33072116
http://dx.doi.org/10.3389/fimmu.2020.573823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539633/
https://www.ncbi.nlm.nih.gov/pubmed/33072116
http://dx.doi.org/10.3389/fimmu.2020.573823

Ejemplares similares